SPADARO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 4.984
EU - Europa 1.279
AS - Asia 896
SA - Sud America 49
AF - Africa 9
Totale 7.217
Nazione #
US - Stati Uniti d'America 4.956
SG - Singapore 332
IN - India 312
SE - Svezia 286
IT - Italia 255
UA - Ucraina 244
CN - Cina 235
FI - Finlandia 209
DE - Germania 88
GB - Regno Unito 52
AR - Argentina 43
IE - Irlanda 34
RU - Federazione Russa 33
CA - Canada 25
RO - Romania 22
BE - Belgio 15
BG - Bulgaria 12
NL - Olanda 10
FR - Francia 7
CH - Svizzera 5
JP - Giappone 4
TG - Togo 4
ZA - Sudafrica 4
HK - Hong Kong 3
ID - Indonesia 3
MX - Messico 3
BR - Brasile 2
CL - Cile 2
CO - Colombia 2
IR - Iran 2
PL - Polonia 2
RS - Serbia 2
AT - Austria 1
AZ - Azerbaigian 1
GR - Grecia 1
IL - Israele 1
KR - Corea 1
LT - Lituania 1
MY - Malesia 1
SC - Seychelles 1
TH - Thailandia 1
Totale 7.217
Città #
Fairfield 756
Chandler 442
Woodbridge 379
Ashburn 341
Seattle 259
Houston 245
Singapore 241
Wilmington 237
Cambridge 215
Ann Arbor 188
Princeton 183
Plano 152
Dearborn 147
Beijing 142
Santa Clara 136
San Paolo di Civitate 125
Boston 111
Jacksonville 108
Lawrence 105
San Diego 61
Helsinki 56
Millbury 52
Des Moines 47
Andover 44
Federal 43
Dublin 34
Boardman 31
Rome 30
San Mateo 28
Norwalk 24
Falls Church 21
Bremen 19
Moscow 19
Toronto 19
Falkenstein 17
Brussels 15
Pune 14
Bühl 13
Nanjing 13
Fasano 12
Fremont 12
Sofia 12
Mannheim 11
Kunming 9
Guangzhou 7
Hefei 7
Indiana 7
Torrimpietra 7
Jinan 6
London 6
New York 6
Paris 6
Southend 6
Redmond 5
Bern 4
Frankfurt am Main 4
Kariya 4
Lomé 4
Los Angeles 4
Modena 4
Shenyang 4
Amsterdam 3
Buffalo 3
Dallas 3
Fuzhou 3
Milan 3
Montréal 3
Muizenberg 3
Ottawa 3
Sham Shui Po 3
Tappahannock 3
Zanè 3
Belgrade 2
Bogotá 2
Changsha 2
Chennai 2
Gela 2
Grandate 2
Mexico City 2
Nanchang 2
Provo 2
Quanzhou 2
Redwood City 2
Semarang 2
Senago 2
Taizhou 2
Timișoara 2
Tivoli 2
Trissino 2
Trumbull 2
Warsaw 2
Yantai 2
Zhengzhou 2
Aprilia 1
Athens 1
Auburn Hills 1
Baku 1
Bangkok 1
Banyumas 1
Bari 1
Totale 5.341
Nome #
LUPUS-ERYTHEMATOSUS PANNICULITIS - AN IMMUNOHISTOCHEMICAL STUDY 93
Assessment of subclinical atherosclerosis in ankylosing spondylitis: Correlations with disease activity indices 92
Biomarkers of Subclinical Atherosclerosis in Patients with Autoimmune Disorders 91
Anti-tissue transglutaminase antibodies in arthritic patients: A disease-specific finding? 89
Pelvis-shoulder coordination during level walking in patients with ankylosing spondylitis 89
Induction of multidrug resistance proteins in lymphocytes from patients with arthritic disorders 88
Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13 88
Protein oxidation markers in the serum and synovial fluid of psoriatic arthritis patients 86
Anti-cyclic citrullinated peptide antibody determination in the synovial fluid of patients with rheumatoid arthritis: comment on the article by Caspi et al. 85
Class specific rheumatoid factors and antiphospholipid syndrome in systemic lupus erythematosus 81
Comparison of ultrasound transmission velocity with computed metacarpal radiogrammetry and dual-photon absorptiometry 81
[Soluble P-selectin levels in synovial fluid and serum from patients with psoriatic arthritis]. 79
Correlazioni dell’età e della durata di menopausa con la velocità di trasmissione degli ultrasuoni (VTU) e con la mineralometria lombare. 78
Adhesion molecule expression in the synovial membrane of psoriatic arthritis 77
LONG-TERM FOLLOW-UP OF LOW-DOSE METHOTREXATE THERAPY IN ONE CASE OF IDIOPATHIC RETROPERITONEAL FIBROSIS 76
Evaluation of degranulation and cytokine production in natural killer cells from spondyloarthritis patients at single-cell level. 76
Systemic sclerosis and multiple sclerosis 75
Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis 74
From rehabilitation to remission in ankylosing spondylitis 73
Anti-tissue transglutaminase antibodies in inflammatory and degenerative arthropathies. 73
Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities 73
The immunology of rheumatoid arthritis 72
Successful Immunosuppressive Treatment of Dermatomyositis: A Nailfold Capillaroscopy Survey 72
Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis 72
Italian consensus on EULAR recommendations 2005 for the management of hip osteoarthritis 71
Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile 71
Soluble interleukin-2-receptor and interleukin-6 changes during low-dose methotrexate treatment in rheumatoid arthritis 69
STERNOCLAVICULAR JOINT DISEASE IN PSORIATIC-ARTHRITIS 69
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy 67
Changes of glycosylation of serum proteins in psoriatic arthritis, studied by enzyme-linked lectin assay (ELLA), using concanavalin A 67
A CASE OF RELAPSING POLYCHONDRITIS - PATHOGENETIC CONSIDERATIONS 67
Psoriatic Arthritis Spondylitis Radiology Index: A Modified Index for Radiologic Assessment of Axial Involvement in Psoriatic Arthritis 67
Relationship of Interleukin-12 and Interleukin-13 imbalance with class-specific rheumatoid factors and anticardiolipin antibodies in systemic lupus erythematosus 65
Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis 65
Soluble interleukin-2 receptor and interleukin-6 levels: Evaluation during cyclosporin a and methotrexate treatment in psoriatic arthritis 64
ONE-YEAR TREATMENT WITH LOW-DOSE METHOTREXATE IN RHEUMATOID-ARTHRITIS - EFFECT ON CLASS-SPECIFIC RHEUMATOID FACTORS 64
Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis. 63
Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis. 62
Changes of glycosylation of serum proteins in Sjogren's syndrome: Correlation with interleukin-6 and soluble interleukin-2 receptor 61
ULTRASOUND TRANSMISSION VELOCITY OF THE PROXIMAL PHALANXES OF THE NON DOMINANT HAND IN THE STUDY OF OSTEOPOROSIS 60
Soluble interleukin-2 receptor in Sjogren's syndrome: Relation to main serum immunological and immunohistochemical parameters 60
Anti-cyclic citrullinated peptide antibody determination in synovial fluid of psoriatic arthritis 59
Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study 59
Oxidative stress parameters in different systemic rheumatic diseases 59
Methotrexate effect on anti-cyclic citrullinated peptide antibody levels in rheumatoid arthritis 59
Italian Society of Rheumatology (SIR) recommendations for performing arthrocentesis 58
Sonographic-detected joint effusion compared with physical examination in the assessment of sacroiliac joints in spondyloarthritis 58
The role of interleukin-12 in immune-mediated rheumatic diseases 58
Psoriatic arthritis: Imaging techniques 57
Down-regulation of cytotoxic expression on peripheral blood mononuclear cells in patiens with primary Sjogren's syndrome 57
Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis. 57
Rehabilitation in Psoriatic Arthritis 57
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study 56
Analisi immunoistochimica dell'espressione delle principali molecole di adesione e dei fattori di necrosi tumorale a livello della membrana sinoviale nell'artrite psoriasica 55
Case definition of psoriatic arthritis 55
Monitoring Biological Therapies in Psoriatic Arthritis 54
Interleukin-6 and soluble interleukin-2 receptor in juvenile chronic arthritis: Correlations with clinical and laboratory parameters 54
MULTIPLE CERVICAL CORD COMPRESSIONS IN PSORIATIC-ARTHRITIS 54
null 54
Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis 53
Anti-cyclic citrullinated peptide antibodies in elderly onset rheumatoid arthritis 53
Ultrasound measurements at the proximal phalanges in male patients with psoriatic arthritis 51
Occupational therapy in ankylosing spondylitis: Short-term prospective study in patients treated with anti-TNF-alpha drugs 51
Avascular necrosis of the femoral head in long-term follow-up of systemic sclerosis: Report of two cases 51
Occupational therapy in rheumatoid arthritis: short term prospective study in patients treated with anti-TNF-alpha drugs. 51
The radiological assessment of axial involvement in psoriatic arthritis 51
Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study 51
Switching tumour necrosis factor alpha antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period 50
Appearance of rheumatoid nodules following anti-tumor necrosis factor alpha treatment with adalimumab for rheumatoid arthritis. 50
LA MANO SCLERODERMICA: EFFETTO DELLA TERAPIA OCCUPAZIONALE SULLO STATO DI SALUTE E SULLA QUALITÀ DELLA VITA 49
Rehabilitation for Ankylosing Spondylitis in the Era of Biologics: Any Room Left for This Treatment? 49
Identification of the Clinical Features Distinguishing Psoriatic Arthritis and Fibromyalgia 49
The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study 49
Italian consensus on Eular 2003 recommendations for the treatment of knee osteoarthritis 49
Correlations between peripheral and axial radiological changes in patients with psoriatic polyarthritis 49
null 47
Artrocentesi 47
Anticorpi anti-cellule endoteliali nella sclerosi sistemica. Correlazioni con le diverse alterazioni capillaroscopiche 47
Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: Correlations with clinical and laboratory parameters 47
Aminopeptidase N (CD13) expression on synovial fluid T lymphocytes from psoriatic arthritis patients 47
Steady-state kinetics of the reaction catalyzed by GMP reductase. 47
SACROILIAC JOINT INVOLVEMENT IN PRIMARY HYPERPARATHYROIDISM - PATHOGENETIC CONSIDERATIONS 47
[Value of cytological analysis of the synovial fluid in multicentric reticulohistiocytosis. A case]. 46
More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis? 46
COMPARISON OF CYCLOSPORINE-A AND METHOTREXATE IN THE TREATMENT OF PSORIATIC-ARTHRITIS - A ONE-YEAR PROSPECTIVE-STUDY 45
Immunohistologic markers of immune activation and changes of glycosylation of serum proteins in primary Sjogren's syndrome 43
Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritis 42
SHORT-TERM CYCLOSPORINE-A THERAPY FOR PSORIATIC-ARTHRITIS 42
Axial psoriatic arthritis: an intriguing clinical entity or a subset of an intriguing disease? 41
Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study 41
Assessment of enthesitis in psoriatic arthritis using Doppler ultrasound energy. Multicenter study 41
MAGNETIC-RESONANCE-IMAGING (MRI) OF THE BRAIN IN SLE - ECLAM AND SLEDAI CORRELATIONS 40
Etanercept in psoriatic arthritis 40
Lupus Eritematoso Sistemico (LES). 40
Assessment of psoriatic nail disease activity by rheumatologists: comment on the article by Lubrano et al Reply 40
Comparison of the health assessment questionnaire and arthritis impact measurement scale in patients with psoriatic arthritis 40
[About "Multiple sclerosis and autoimmune diseases" ]. 39
The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods 38
anticorpi anti-peptidi citrullinati e fattore reumatoide nel monitoraggio clinico della terapia dell'artrite reumatoide 38
Interleukin-13 in synovial fluid and serum of psoriatic arthritis 37
Totale 5.939
Categoria #
all - tutte 22.405
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.405


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.091 0 0 0 0 0 256 218 182 152 166 93 24
2020/2021453 55 51 22 55 7 38 10 57 35 61 42 20
2021/20221.571 3 111 135 51 212 41 31 147 130 150 255 305
2022/20231.530 338 365 76 174 154 162 25 67 94 15 37 23
2023/2024556 48 91 12 26 28 40 24 90 6 70 55 66
2024/2025501 51 55 80 31 95 189 0 0 0 0 0 0
Totale 7.329